Naratriptan Inteli

Medicinal product

(Invented) name

Naratriptan Inteli

Active substance (s)

Naratriptanas

Strength

2,5 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N02CC02, Naratriptan

Marketing authorisation holder

UAB Inteli Generics Nord, Lietuva

Date of authorisation

2019-10-01

Date of renewal

2024-11-22

Documents

Naratriptan Inteli_plėvele dengtos tabletės_viesas_AR.pdf

4448 pakuotes lapelis_2024-11-22.doc

4448 Naratriptan_Inteli_perr2024-11-22.doc

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Naratriptanas	2,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102414	88514	1088514	lizdinė plokštelė	N2 (oPA/Al/PVC)		Receptinis	LT/1/19/4448/001	Tiekiama	-	-	No	-	-	Download
102415	88515	1088515	lizdinė plokštelė	N2 (PVC/PE/PCTE)		Receptinis	LT/1/19/4448/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-11-22	Perregistruotas
2019-10-01	Registruotas